COMMUNIQUÉS West-GlobeNewswire

Ziopharm Oncology Initiates Phase 2 Trial Evaluating Combination Therapy of Controlled IL-12 with Libtayo® (cemiplimab-rwlc) to Treat Patients with Recurrent Glioblastoma
27/06/2019
Phase 2 trial will enroll approximately 30 patients and evaluate both safety and efficacy BOSTON, June 27, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced [...]
b-2Cool’s U.S. Strategy Extinguishes Fires to Reshape Native Type II Collagen Market
27/06/2019
ANN ARBOR, Mich., June 27, 2019 (GLOBE NEWSWIRE) -- Bioiberica’s entry into the U.S. market for its native (undenatured) type II collagen, b-2Cool, through exclusive distributer Berg Nutrition, was initially met with [...]
Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments
27/06/2019
-- Achieved Fourth Quarter Revenue of $17.1 Million, an Increase of 146% Compared to Prior Year Quarter -- -- Generated Income From Continuing Operations During the Fourth Quarter of Fiscal 2019 -- -- Increasing Demand [...]
Homology Medicines Announces Leadership Updates
27/06/2019
- Sam Rasty, Ph.D., Departs as Chief Operating Officer to Lead an Emerging Biotech - BEDFORD, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced [...]
Arcturus Therapeutics Receives Orphan Drug Designation from the U.S. FDA for ARCT-810, for Treatment of Ornithine Transcarbamylase (OTC) Deficiency
27/06/2019
SAN DIEGO, June 27, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics towards rare, liver and [...]
Verrica Pharmaceuticals Enrolls First Patient in Phase 2 Trial of VP-102 for the Treatment of External Genital Warts
27/06/2019
WEST CHESTER, Pa., June 27, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that [...]
Theratechnologies to Announce Financial Results for Second Quarter 2019
27/06/2019
MONTREAL, June 27, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) ( Theratechnologies ) announced today that it will issue its financial results for the second quarter ended May 31, 2019, on Thursday, July 11 [...]
Theratechnologies annoncera ses résultats du deuxième trimestre de 2019
27/06/2019
MONTRÉAL, 27 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. («Theratechnologies») (TSX : TH) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers jeudi le 11 juillet 2019 pour le trimestre terminé le [...]
Bone Therapeutics successfully raises EUR 8.5 million
27/06/2019
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO [...]
Bone Therapeutics lève avec succès 8,5 M€
27/06/2019
LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, EN AUSTRALIE, AU CANADA, AU JAPON, EN AFRIQUE DU SUD, OU DANS TOUT AUTRE [...]
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Lenalidomide and Dexamethasone in Frontline Multiple Myeloma
27/06/2019
Company Announcement DARZALEX (daratumumab) approved by U.S. FDA in combination with lenalidomide and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for [...]
Wave Life Sciences annonce le début de DYSTANCE 51, un essai clinique de phase 2/3 sur le Suvodirsen
27/06/2019
L'étude mondiale a été conçue pour évaluer l'efficacité et l'innocuité de Suvodirsen chez les patients atteints de myopathie de Duchenne (DMD) favorables au saut d'exon 51 Les résultats sont destinés à soutenir les [...]
Leading Independent Provider Association Nivano Physicians, Inc. Announces Medicare Contract with Anthem BlueCross
27/06/2019
SACRAMENTO, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- One of Northern California’s leading Independent Physician Associations (IPA), Nivano Physicians, Inc., today announced the signing of a Medicare contract with [...]
Allergy Therapeutics plc - Successful litigation settlement relating to PQ Grass Phase II Trial
27/06/2019
Allergy Therapeutics plc (“Allergy Therapeutics”, “ATL” or the “Group”) Successful litigation settlement relating to PQ Grass Phase II Trial 27 June 2019 Allergy Therapeutics plc (AIM: AGY), the fully integrated [...]
Louise Bradley, MHCC president and CEO, named Member of the Order of Canada
27/06/2019
OTTAWA, June 27, 2019 (GLOBE NEWSWIRE) -- Today, the Office of the Secretary of the Governor General announced that Her Excellency the Right Honourable Julie Payette has conferred upon Louise Bradley, president and CEO [...]
Louise Bradley, présidente et directrice générale de la CSMC, nommée Membre de l’Ordre du Canada
27/06/2019
OTTAWA, 27 juin 2019 (GLOBE NEWSWIRE) -- Aujourd’hui, le Bureau du secrétaire de la gouverneure générale a annoncé que Son Excellence la très honorable Julie Payette a conféré à Louise Bradley, présidente et directrice [...]
Cytovance® Biologics Inc. appoints Dr. Jesse McCool as Chief Technology Officer
27/06/2019
Cytovance ® Biologics Inc. announced that Dr. Jesse McCool will serve the company as CTO, effective June 27, 2019 OKLAHOMA CITY, June 27, 2019 (GLOBE NEWSWIRE) -- Cytovance ® Biologics, a leading biopharmaceutical [...]
Allergy Therapeutics plc - Trading Update and Successful Litigation Settlement
27/06/2019
Allergy Therapeutics plc (“Allergy Therapeutics” or the “Group”) Trading Update and Successful Litigation Settlement 2019 full year earnings expected to be ahead of market expectations 27 June 2019 Allergy Therapeutics [...]
Medtronic Completes Acquisition of Titan Spine
27/06/2019
Acquisition Accelerates Medtronic’s Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions DUBLIN, June 27, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader [...]

Pages